Logo for Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Investor Relations Material

Latest events

Logo for Rigel Pharmaceuticals Inc

Q1 2025

Rigel Pharmaceuticals
Logo for Rigel Pharmaceuticals

Q1 2025

6 May, 2025
Logo for Rigel Pharmaceuticals

Q4 2024

4 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Rigel Pharmaceuticals Inc

Access all reports
Rigel Pharmaceuticals Inc. is a biotechnology company focused on discovering, developing, and commercializing small-molecule drugs for immune and hematologic disorders, as well as rare diseases. The company’s research and development efforts target critical pathways in the immune system to address conditions with significant unmet medical needs. Rigel also partners with other pharmaceutical companies to advance its therapeutic candidates. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.